(2R,3S,4R,5S)-2-(hydroxymethyl)-5-(2-(5-methyl-4-phenyl-1H-1,2,3-triazol-1-yl)ethyl)-tetrahydrofuran-3,4-diol

ID: ALA397507

Chembl Id: CHEMBL397507

PubChem CID: 16739306

Max Phase: Preclinical

Molecular Formula: C16H21N3O4

Molecular Weight: 319.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(-c2ccccc2)nnn1CC[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C16H21N3O4/c1-10-14(11-5-3-2-4-6-11)17-18-19(10)8-7-12-15(21)16(22)13(9-20)23-12/h2-6,12-13,15-16,20-22H,7-9H2,1H3/t12-,13+,15-,16+/m0/s1

Standard InChI Key:  NHLLNRIBZYPEHA-LQKXBSAESA-N

Associated Targets(non-human)

IAG-nucleoside hydrolase (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 319.36Molecular Weight (Monoisotopic): 319.1532AlogP: 0.13#Rotatable Bonds: 5
Polar Surface Area: 100.63Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.80CX Basic pKa: 0.25CX LogP: 0.26CX LogD: 0.26
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: -0.06

References

1. Goeminne A, McNaughton M, Bal G, Surpateanu G, Van der Veken P, De Prol S, Versées W, Steyaert J, Apers S, Haemers A, Augustyns K..  (2007)  1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.,  17  (9): [PMID:17317181] [10.1016/j.bmcl.2007.02.017]

Source